In conjunction with traditional modular bifurcated aortic endografts, bilateral iliac branch endoprostheses have been safely and effectively used for treatment of bilateral iliac artery aneurysms. However, anatomic constraints, such as inadequate renal artery to iliac bifurcation lengths and unfavorable aortic anatomy, can preclude deployment in certain configurations and limit use in many patients. We present an innovative technique to overcome such anatomic constraints and to extend the reach of iliac branch endoprosthesis technology in patients with iliac artery aneurysms. (J Vasc Surg Cases and Innovative Techniques 2019;5:174-8.) 
Common iliac artery (CIA) aneurysms may extend to and include the iliac bifurcation, complicating treatment of isolated CIA aneurysms with endovascular methods. Recently, iliac branch endoprostheses (IBEs) have been used to preserve internal iliac artery (IIA) patency during endovascular repair of CIA or aortoiliac aneurysms that lack an adequate CIA distal landing zone. Studies reported successful repair of CIA aneurysms initially with the Zenith IBE (Cook Medical, Bloomington, Ind) 1, 2 and later with the Excluder IBE (Gore Medical, Flagstaff, Ariz). [3] [4] [5] Although only a minority of patients in these trials had bilateral CIA aneurysms, Maldonado et al 6 recently showed excellent technical success and shortterm patency rates for bilateral Gore IBEs in patients with bilateral CIA aneurysms. Whereas small case series and scant case reports have reported on the successful off-label use of isolated IBEs for treatment of isolated iliac artery aneurysms, the instructions for use (IFU) recommend the use of the Gore IBE in conjunction with the Excluder aortic endoprosthesis. This on-label combination, however, requires specific renal artery to iliac bifurcation lengths as well as aortic luminal adequacy to accommodate a modular bifurcated device and to facilitate contralateral gate opening and cannulation (Table) . Concomitant aortoiliac occlusive disease, narrow distal aortic domain, and inadequate renal artery to iliac bifurcation lengths preclude application of IBE technology. Herein, we describe a novel approach with off-label use of endograft devices that overcome these specific anatomic restrictions and facilitate deployment of bilateral IBEs for repair of bilateral CIA aneurysms. This technique can also be applied to unilateral CIA aneurysms.
CASE REPORT
Presentation. An 82-year-old man with a history of hypertension, hyperlipidemia, myocardial infarction, coronary artery bypass surgery, chronic obstructive pulmonary disease requiring home oxygen, and colon cancer requiring partial colectomy was referred for evaluation and treatment of expanding bilateral CIA aneurysms measuring 3.5 to 4 cm on computed tomography angiography (CTA ; Fig 1, A) . The inferior mesenteric artery and IIA were noted to be patent. Given the history of colon resection and the inherent mesenteric flow disruption, maintaining IIA flow would preserve the superior rectal arterial collateral network. Therefore, to preserve pelvic and colon perfusion, placement of bilateral IBEs was preferred. However, CTA and centerline three-dimensional reconstruction showed a short, diseased infrarenal aorta unable to accommodate a traditional modular bifurcated device (Fig 1, B and C ). In addition, there were inadequate proximal CIA IBE landing zones, precluding IBE insertion without an aortic component. To overcome these anatomic restrictions, a bifurcated unibody aortic endoprosthesis (AFX; Endologix, Irvine, Calif) was used to reconstruct the aortic bifurcation (Fig 1, D and E) and to accommodate adequate proximal iliac landing zones for bilateral IBE and over the bifurcation to minimize the risk of snaring the wire through the interstices of the AFX stent struts (Fig 2, B) . Completion angiography showed a widely patent aortoiliac system and distal runoff with complete exclusion of the CIA aneurysms and no evidence of endoleak on acute-or delayedphase angiography (Fig 2, E) .
Postoperative course. The patient had no perioperative complications and was discharged home on postoperative day 1. Follow-up CTA at 30 days revealed a patent reconstruction with no evidence of type I, type II, or type III endoleak or stent graft incompatibility (Fig 2, F) . On 6-month follow-up imaging, the iliac aneurysms were reduced in size to 3.1 cm bilaterally. The stents were widely patent with no evidence of endoleak or migration (Fig 2, G) . The patient consented to publication of this report.
DISCUSSION
This is the first report to date describing the use of a bifurcated unibody aortic endograft to facilitate bilateral IBE deployment. By relining and reconstructing the aortic bifurcation, we developed new proximal CIA landing zones for the IBE main body on each side; the new proximal landing zones obviate inadequate renal artery to iliac bifurcation lengths by forgoing the need for concomitant deployment of a traditional modular bifurcated aortic endograft. An additional benefit is avoiding the need to open and to cannulate a contralateral gate in a narrow, diseased infrarenal aorta. Furthermore, the possibility of iliac limb stenosis in a narrow, diseased aorta was also eliminated. Although it was not necessary in this case, more proximal placement of the AFX endograft may provide even more working length for IBE positioning and be a necessary maneuver in some patients. Whereas most patients can tolerate unilateral IIA occlusion, the rate of pelvic ischemia secondary to unilateral IIA occlusion remains relatively high. A meta-analysis of 61 studies including 1125 patients undergoing unilateral IIA occlusion reported a 29.2% incidence of buttock claudication and 10% incidence of erectile dysfunction. 7 Given this patient's history of colon resection that likely disrupted the collateral pelvic vascular network, we preserved bilateral IIA flow at the time of aneurysm repair.
The IFU-based anatomic limitations preclude a large number of CIA aneurysms from IBE treatment. Approximately one-third of the patients in two large studies did not meet the IFU criteria for commercially available IBEs. 8, 9 Pearce et al 10 reported that only 18% to 25% of screened patients were eligible for IBE purely on the basis of anatomic criteria. The most common exclusion criterion for the Gore IBE is inadequate proximal CIA diameter to allow complete opening of the device. Concomitant use of Gore Excluder further restricts eligibility for bilateral IBEs on the basis of the requirement of a renal artery to iliac bifurcation length of $195 mm to accommodate the Excluder iliac limb and the bilateral IBE main bodies. 6 Maldonado et al 6 highlighted this limitation as 46% of patients were ineligible for implantation of bilateral Gore IBEs. Whereas this technique extends the reach of IBE technology, it does not address inadequate CIA diameters or IIA seal zones. It is solely recommended as an adjunctive technique to facilitate IBE in patients with inadequate proximal CIA seal zone or short aortoiliac anatomy that precludes concomitant use of a modular bifurcated aortic endograft and associated iliac limbs.
